NCT07390721 Diaphragmatic Kinesio Taping With HIIT in Trained Individuals
| NCT ID | NCT07390721 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Agri Ibrahim Cecen University |
| Condition | Postural Balance |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-11-30 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This study examines whether adding diaphragmatic kinesio taping to high-intensity interval training (HIIT) improves physical performance in trained individuals. Participants will be randomly assigned to one of two groups. One group will perform an 8-week HIIT program on a cycle ergometer. The other group will follow the same HIIT program and will also receive diaphragmatic kinesio taping before each exercise session. The taping is applied to support breathing muscles and may help improve oxygen use during exercise. Before and after the training period, participants will undergo tests to measure aerobic capacity (VO₂max), anaerobic power (Wingate test), balance (Y-Balance test), lung function (spirometry), body composition, and heart rate responses. The results of this study will help determine whether diaphragmatic kinesio taping provides additional benefits when combined with HIIT training.
Eligibility Criteria
Inclusion Criteria: * Aged 18-35 years * Male or female trained individuals * At least 6 months of regular training history * Training at least 3-5 days per week * Estimated VO₂max ≥ 50 ml/kg/min * No known contraindication to high-intensity exercise * No allergy or skin condition preventing kinesio taping * Able to provide written informed consent Exclusion Criteria: * History of cardiovascular, respiratory, or metabolic disease (e.g., asthma, COPD, diabetes, heart disease) * Major musculoskeletal injury or surgery within the past 6 months * Any pathology affecting diaphragm or respiratory muscles * Active smoking or substance abuse * Use of performance-enhancing drugs * Skin disease in the abdominal region